Fundies.
English

OptimizeRx Corp

EDGAR
OPRX Quarterly report (10-Q) · filed 2026-08-13

Annual consolidated revenue for 2025: about USD 109.4M, using the latest reported figures. The previous period, 2024, was about USD 92.13M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

20.5 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

-0.43%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -88000 USD Source
  • Revenue: 20504000 USD Source

Operating cash flow

8.61 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: 8144000 USD Source
  • Operating Cash Flow: -467000 USD Source

Free cash flow

8.58 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: 8144000 USD Source
  • Operating Cash Flow: -467000 USD Source
  • Capital Expenditure: 56000 USD Source
  • Capital Expenditure: 21000 USD Source
Cash and cash equivalents
24.1 million USD Source
Exact value

24096000 USD

Long-term debt including current maturities
19.7 million USD Source
Exact value

19688000 USD

Shares outstanding
18.8 million shares Source
Exact value

18832836 shares

Reported share-count change

1.49% · 277 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 18555991 shares · 2025-06-30· Source
  • 18832836 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

98.7 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Revenue: 26067000 USD · 2025-07-01 – 2025-09-30 Source
  • Revenue: 109429000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 77190000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 19844000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 20504000 USD · 2026-04-01 – 2026-06-30 Source

Net income

4.6 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: 779000 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: 5132000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: 112000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -495000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -703000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

18.4 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: 11627000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: 8425000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: 18715000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: 11627000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -467000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: 8144000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -467000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

77 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Capital expenditure: 47000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 37000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 58000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 47000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 21000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 56000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 21000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

18.4 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: 11627000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: 8425000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: 18715000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: 11627000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -467000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: 8144000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -467000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 47000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 37000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 58000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 47000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 21000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 56000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 21000 USD · 2026-01-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 11 of 11 periods available· newest 2025-12-31
  • Operating income: 11 of 11 periods available· newest 2025-12-31
  • Net income: 11 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 11 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 11 of 11 periods available· newest 2025-12-31
  • Total assets: 11 of 11 periods available· newest 2025-12-31
  • Total liabilities: 9 of 11 periods available· newest 2025-12-31
  • Current assets: 11 of 11 periods available· newest 2025-12-31
  • Current liabilities: 11 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
  • Long-term debt including current maturities: 3 of 11 periods available· newest 2025-12-31
  • Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +18.8%

    Prior period

    USD 92.13 million

    –

    Current period

    USD 109.43 million

    –

    Exact inputs and evidence

    109429000 − 92127000 = 17302000 USD

    92127000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    109429000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 25.24 million

    Prior period

    −USD 20.11 million

    –

    Current period

    USD 5.13 million

    –

    Exact inputs and evidence

    5132000 − -20110000 = 25242000 USD

    -20110000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    5132000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +282.8%

    Prior period

    USD 4.89 million

    –

    Current period

    USD 18.72 million

    –

    Exact inputs and evidence

    18715000 − 4889000 = 13826000 USD

    4889000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    18715000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -48.2%

    Prior period

    USD 112,000

    –

    Current period

    USD 58,000

    –

    Exact inputs and evidence

    58000 − 112000 = -54000 USD

    112000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    58000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 109.43 million 100% of revenue
  • Cost of revenue USD 35.83 million 33% of revenue
  • Operating expenses USD 61.9 million 57% of revenue
  • Operating income USD 11.69 million 11% of revenue
  • Tax, interest and other Derived USD 6.56 million 6% of revenue
  • Net income USD 5.13 million 4.7% of revenue

Cash

  • Operating cash flow USD 18.72 million 17% of revenue
  • Capital expenditure USD 58,000 0.1% of revenue
  • Free cash flow Derived USD 18.66 million 17% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2016 Operating loss: operating costs were 120% of revenue.
  • 2017 Operating loss: operating costs were 118% of revenue.
  • 2018 Net income was higher than operating income, so the split is not drawn.
  • 2019 Operating loss: operating costs were 115% of revenue.
  • 2020 Operating loss: operating costs were 105% of revenue.
  • 2021 Net income was higher than operating income, so the split is not drawn.
  • 2022 Operating loss: operating costs were 120% of revenue.
  • 2023 Operating loss: operating costs were 137% of revenue.
  • 2024 Operating loss: operating costs were 115% of revenue.
  • 2025 89%
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2016 2016-01-01 – 2016-12-317751462 9332974 Derived -1581512 -42309 Derived -1539203 -644399 Derived
Source
2017 2017-01-01 – 2017-12-3112127422 14257388 Derived -2129966 -25937 Derived -2104029 -1522074 Derived
Source
2018 2018-01-01 – 2018-12-3121206363 21026231 Derived 180132 -46212 Derived 226344 758193 Derived
Source
2019 2019-01-01 – 2019-12-3124598274 28291838 Derived -3693564 -550988 Derived -3142576 -1748513 Derived
Source
2020 2020-01-01 – 2020-12-3143313323 45448642 Derived -2135319 71808 Derived -2207127 -6378427 Derived
Source
2021 2021-01-01 – 2021-12-314516668 4155568 Derived 361100 -16979 Derived 378079 625717 Derived
Source
2022 2022-01-01 – 2022-12-3162450156 74740894 Derived -12290738 -852298 Derived -11438440 10573073 Derived
Source
2023 2023-01-01 – 2023-12-3171522000 97924000 Derived -26402000 -8836000 Derived -17566000 -7327000 Derived
Source
2024 2024-01-01 – 2024-12-3192127000 105833000 Derived -13706000 6404000 Derived -20110000 4777000 Derived
Source
2025 2025-01-01 – 2025-12-31109429000 97736000 Derived 11693000 6561000 Derived 5132000 18657000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 109.4M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.118.2M88.6M59.1M29.5M0.0201620212025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Revenue7751462
2017Revenue12127422
2018Revenue21206363
2019Revenue24598274
2020Revenue43313323
2021Revenue4516668
2022Revenue62450156
2023Revenue71522000
2024Revenue92127000
2025Revenue109429000

Revenue growth

Change in revenue from the same financial period one year earlier.

18.8% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1,392%994%597%199%-199%201620212025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2016Year over year7.4%
2017Year over year56.5%
2018Year over year74.9%
2019Year over year16%
2020Year over year76.1%
2021Year over year-89.6%
2022Year over year1,282.7%
2023Year over year14.5%
2024Year over year28.8%
2025Year over year18.8%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 10.7% 2025
Net margin 4.7% 2025
Free cash flow margin 17% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.21%6%-10%-26%-41%201620212025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2016Operating margin-20.4%
2017Operating margin-17.6%
2018Operating margin0.8%
2019Operating margin-15%
2020Operating margin-4.9%
2021Operating margin8%
2022Operating margin-19.7%
2023Operating margin-36.9%
2024Operating margin-14.9%
2025Operating margin10.7%
2016Net margin-19.9%
2017Net margin-17.3%
2018Net margin1.1%
2019Net margin-12.8%
2020Net margin-5.1%
2021Net margin8.4%
2022Net margin-18.3%
2023Net margin-24.6%
2024Net margin-21.8%
2025Net margin4.7%
2016Free cash flow margin-8.3%
2017Free cash flow margin-12.6%
2018Free cash flow margin3.6%
2019Free cash flow margin-7.1%
2020Free cash flow margin-14.7%
2021Free cash flow margin13.9%
2022Free cash flow margin16.9%
2023Free cash flow margin-10.2%
2024Free cash flow margin5.2%
2025Free cash flow margin17%

Operating cash flow

Cash generated by the company’s normal business operations.

USD 18.7M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.20.8M13.3M5.7M-1.8M-9.3M201620212025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Operating cash flow-465965
2017Operating cash flow-1479831
2018Operating cash flow792555
2019Operating cash flow-1660796
2020Operating cash flow-6310386
2021Operating cash flow726039
2022Operating cash flow10654078
2023Operating cash flow-7240000
2024Operating cash flow4889000
2025Operating cash flow18715000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 18.7M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.20.7M13.2M5.7M-1.9M-9.4M201620212025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Free cash flow-644399
2017Free cash flow-1522074
2018Free cash flow758193
2019Free cash flow-1748513
2020Free cash flow-6378427
2021Free cash flow625717
2022Free cash flow10573073
2023Free cash flow-7327000
2024Free cash flow4777000
2025Free cash flow18657000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

27.5% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.39.2%29.4%19.6%9.8%0.0%2016-12-3120212025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2016-12-31Liabilities / assetsNot reported
2017Liabilities / assets36.3%
2018Liabilities / assets26.3%
2019Liabilities / assets20.8%
2020Liabilities / assets17.2%
2021Liabilities / assets6.8%
2022Liabilities / assets6.3%
2023Liabilities / assets31%
2024Liabilities / assets31.6%
2025Liabilities / assets27.5%

Current assets to current liabilities

Current assets divided by current liabilities.

3.04× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.13.27×9.95×6.63×3.32×0.00×201620212025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2016Current assets / current liabilities2.78×
2017Current assets / current liabilities2.49×
2018Current assets / current liabilities3.72×
2019Current assets / current liabilities4.44×
2020Current assets / current liabilities3.28×
2021Current assets / current liabilities12.29×
2022Current assets / current liabilities11.74×
2023Current assets / current liabilities3.04×
2024Current assets / current liabilities2.89×
2025Current assets / current liabilities3.04×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2016-01-01 – 2016-12-31
−USD 1.54 million
Exact value

Exact value: -1539203 USD

2016-01-01 – 2016-12-31: -1539203 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 465,965
Exact value

Exact value: -465965 USD

2016-01-01 – 2016-12-31: -465965 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 178,434
Exact value

Exact value: 178434 USD

2016-01-01 – 2016-12-31: 178434 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 644,399
Calculation and evidence

-465965 − 178434 USD

Exact free cash flow: -644399 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
−USD 2.1 million
Exact value

Exact value: -2104029 USD

2017-01-01 – 2017-12-31: -2104029 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.48 million
Exact value

Exact value: -1479831 USD

2017-01-01 – 2017-12-31: -1479831 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 42,243
Exact value

Exact value: 42243 USD

2017-01-01 – 2017-12-31: 42243 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.52 million
Calculation and evidence

-1479831 − 42243 USD

Exact free cash flow: -1522074 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
USD 226,344
Exact value

Exact value: 226344 USD

2018-01-01 – 2018-12-31: 226344 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 792,555
Exact value

Exact value: 792555 USD

2018-01-01 – 2018-12-31: 792555 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 34,362
Exact value

Exact value: 34362 USD

2018-01-01 – 2018-12-31: 34362 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 758,193
Calculation and evidence

792555 − 34362 USD

Exact free cash flow: 758193 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 3.14 million
Exact value

Exact value: -3142576 USD

2019-01-01 – 2019-12-31: -3142576 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.66 million
Exact value

Exact value: -1660796 USD

2019-01-01 – 2019-12-31: -1660796 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 87,717
Exact value

Exact value: 87717 USD

2019-01-01 – 2019-12-31: 87717 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.75 million
Calculation and evidence

-1660796 − 87717 USD

Exact free cash flow: -1748513 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 2.21 million
Exact value

Exact value: -2207127 USD

2020-01-01 – 2020-12-31: -2207127 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 6.31 million
Exact value

Exact value: -6310386 USD

2020-01-01 – 2020-12-31: -6310386 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 68,041
Exact value

Exact value: 68041 USD

2020-01-01 – 2020-12-31: 68041 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 6.38 million
Calculation and evidence

-6310386 − 68041 USD

Exact free cash flow: -6378427 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
USD 378,079
Exact value

Exact value: 378079 USD

2021-01-01 – 2021-12-31: 378079 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 726,039
Exact value

Exact value: 726039 USD

2021-01-01 – 2021-12-31: 726039 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 100,322
Exact value

Exact value: 100322 USD

2021-01-01 – 2021-12-31: 100322 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 625,717
Calculation and evidence

726039 − 100322 USD

Exact free cash flow: 625717 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 11.44 million
Exact value

Exact value: -11438440 USD

2022-01-01 – 2022-12-31: -11438440 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 10.65 million
Exact value

Exact value: 10654078 USD

2022-01-01 – 2022-12-31: 10654078 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 81,005
Exact value

Exact value: 81005 USD

2022-01-01 – 2022-12-31: 81005 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 10.57 million
Calculation and evidence

10654078 − 81005 USD

Exact free cash flow: 10573073 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 17.57 million
Exact value

Exact value: -17566000 USD

2023-01-01 – 2023-12-31: -17566000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 7.24 million
Exact value

Exact value: -7240000 USD

2023-01-01 – 2023-12-31: -7240000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 87,000
Exact value

Exact value: 87000 USD

2023-01-01 – 2023-12-31: 87000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 7.33 million
Calculation and evidence

-7240000 − 87000 USD

Exact free cash flow: -7327000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 20.11 million
Exact value

Exact value: -20110000 USD

2024-01-01 – 2024-12-31: -20110000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4.89 million
Exact value

Exact value: 4889000 USD

2024-01-01 – 2024-12-31: 4889000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 112,000
Exact value

Exact value: 112000 USD

2024-01-01 – 2024-12-31: 112000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4.78 million
Calculation and evidence

4889000 − 112000 USD

Exact free cash flow: 4777000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
USD 5.13 million
Exact value

Exact value: 5132000 USD

2025-01-01 – 2025-12-31: 5132000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 18.72 million
Exact value

Exact value: 18715000 USD

2025-01-01 – 2025-12-31: 18715000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 58,000
Exact value

Exact value: 58000 USD

2025-01-01 – 2025-12-31: 58000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 18.66 million
Calculation and evidence

18715000 − 58000 USD

Exact free cash flow: 18657000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

122 filings · 4,077 latest values · 4,077 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001448431, 1448431, OPRX, edgar:1448431

Also known as OptimizeRx Corp, OptimizeRx Corporation